UY26286A1 - Gen de streptomyces avermitilis que dirige la relación de avermectinas b2:b1 - Google Patents

Gen de streptomyces avermitilis que dirige la relación de avermectinas b2:b1

Info

Publication number
UY26286A1
UY26286A1 UY26286A UY26286A UY26286A1 UY 26286 A1 UY26286 A1 UY 26286A1 UY 26286 A UY26286 A UY 26286A UY 26286 A UY26286 A UY 26286A UY 26286 A1 UY26286 A1 UY 26286A1
Authority
UY
Uruguay
Prior art keywords
ratio
directs
streptomyces avermitilis
avermitilis
avermitilis gene
Prior art date
Application number
UY26286A
Other languages
English (en)
Inventor
Yan Chen Gustafsson K Stutzman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY26286A1 publication Critical patent/UY26286A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a moléculas polinucleiotidicas que comprenden secuencias de nucleótidos que codifican un producto génico avec, moléculas polinucleotidicas que pueden usarse para alterar la relación o cantidad de avermectinas de clases 2:1 producidas en cultivos de fermentación de s. avermitilis. La presente invención se refiere además a vectores, células huésped y cepas mutantes de s. avermitilis en las que el gen avec se ha inactivado o mutado para cambiar la relación o cantidad de avermectinas de clases 2:1 producidas.
UY26286A 1999-08-12 2000-08-10 Gen de streptomyces avermitilis que dirige la relación de avermectinas b2:b1 UY26286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14864599P 1999-08-12 1999-08-12

Publications (1)

Publication Number Publication Date
UY26286A1 true UY26286A1 (es) 2001-03-16

Family

ID=22526696

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26286A UY26286A1 (es) 1999-08-12 2000-08-10 Gen de streptomyces avermitilis que dirige la relación de avermectinas b2:b1

Country Status (39)

Country Link
US (3) US6632673B1 (es)
EP (1) EP1200606B1 (es)
JP (1) JP3884651B2 (es)
KR (1) KR100489856B1 (es)
CN (1) CN1186446C (es)
AP (1) AP2002002418A0 (es)
AR (1) AR022646A1 (es)
AT (1) ATE341632T1 (es)
AU (1) AU778837B2 (es)
BG (1) BG65902B1 (es)
BR (1) BRPI0013119B8 (es)
CA (1) CA2380872C (es)
CO (1) CO5290295A1 (es)
CY (1) CY1105778T1 (es)
CZ (1) CZ304402B6 (es)
DE (1) DE60031126T2 (es)
DK (1) DK1200606T3 (es)
EA (1) EA200200056A1 (es)
ES (1) ES2272299T3 (es)
GT (1) GT200000136A (es)
HK (1) HK1046710B (es)
HR (1) HRP20020130A2 (es)
HU (1) HU230600B1 (es)
IL (2) IL147563A0 (es)
IS (1) IS6250A (es)
MA (1) MA26813A1 (es)
MX (1) MXPA02001513A (es)
NO (1) NO20020664L (es)
NZ (1) NZ516517A (es)
OA (1) OA11998A (es)
PA (1) PA8499501A1 (es)
PE (1) PE20010690A1 (es)
PL (1) PL203818B1 (es)
PT (1) PT1200606E (es)
SK (1) SK288086B6 (es)
TN (1) TNSN00171A1 (es)
UY (1) UY26286A1 (es)
WO (1) WO2001012821A1 (es)
ZA (1) ZA200201072B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012821A1 (en) * 1999-08-12 2001-02-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
JP2005517406A (ja) * 2002-02-12 2005-06-16 ファイザー・プロダクツ・インク B2:B1アベルメクチン比を支配するStreptomycesavermitilis遺伝子
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
KR102657859B1 (ko) 2021-04-07 2024-04-16 윤재식 일체형 내화 소켓

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
IN167980B (es) * 1987-01-23 1991-01-19 Pfizer
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
EP0313297B1 (en) 1987-10-23 1993-05-19 Pfizer Inc. Process for production of avermectin aglycones and cultures therefor
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
NZ233116A (en) 1989-03-31 1994-09-27 Merck & Co Inc Cloning genes from steptomyces avermitilis for avermectin biosynthesis
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
CA2167520C (en) 1993-07-30 1999-07-27 Claudio D. Denoya Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
JP2001504325A (ja) 1996-09-27 2001-04-03 マキシジェン,インコーポレイテッド 回帰的配列シャフリングおよび選択による遺伝子治療の最適化のための方法
EP2261373A3 (en) 1997-01-17 2011-12-14 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
CN1521180A (zh) * 1998-02-13 2004-08-18 �Ʒ� 介导除虫菌素b2:b1比例的除虫链霉菌基因
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
WO2001012821A1 (en) * 1999-08-12 2001-02-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Also Published As

Publication number Publication date
HUP0202487A3 (en) 2004-07-28
BG106479A (bg) 2002-10-31
PL203818B1 (pl) 2009-11-30
MA26813A1 (fr) 2004-12-20
CY1105778T1 (el) 2011-02-02
PA8499501A1 (es) 2001-12-14
WO2001012821A1 (en) 2001-02-22
EP1200606B1 (en) 2006-10-04
JP3884651B2 (ja) 2007-02-21
HK1046710B (zh) 2005-05-13
IL147563A (en) 2009-06-15
CA2380872C (en) 2007-11-27
JP2003507017A (ja) 2003-02-25
PE20010690A1 (es) 2001-07-06
CO5290295A1 (es) 2003-06-27
AP2002002418A0 (en) 2002-03-31
GT200000136A (es) 2002-02-01
DE60031126D1 (de) 2006-11-16
DE60031126T2 (de) 2007-02-08
CA2380872A1 (en) 2001-02-22
US6632673B1 (en) 2003-10-14
HRP20020130A2 (en) 2003-06-30
ZA200201072B (en) 2003-04-30
AU778837B2 (en) 2004-12-23
BR0013119A (pt) 2002-04-23
CN1186446C (zh) 2005-01-26
EP1200606A1 (en) 2002-05-02
MXPA02001513A (es) 2002-07-02
CZ2002296A3 (cs) 2002-08-14
BR0013119B1 (pt) 2014-02-25
US20030232415A1 (en) 2003-12-18
PT1200606E (pt) 2006-12-29
PL353874A1 (en) 2003-12-01
NO20020664D0 (no) 2002-02-11
HU230600B1 (hu) 2017-02-28
TNSN00171A1 (fr) 2005-11-10
NO20020664L (no) 2002-02-11
KR20020029379A (ko) 2002-04-18
US7858340B2 (en) 2010-12-28
KR100489856B1 (ko) 2005-05-17
DK1200606T3 (da) 2007-01-08
HK1046710A1 (en) 2003-01-24
BRPI0013119B8 (pt) 2021-05-25
SK288086B6 (sk) 2013-06-03
ATE341632T1 (de) 2006-10-15
IS6250A (is) 2002-01-25
OA11998A (en) 2006-04-18
HUP0202487A2 (en) 2002-10-28
AU5838600A (en) 2001-03-13
BG65902B1 (bg) 2010-04-30
SK1392002A3 (en) 2002-12-03
ES2272299T3 (es) 2007-05-01
CN1373809A (zh) 2002-10-09
US20040009560A1 (en) 2004-01-15
EA200200056A1 (ru) 2002-06-27
CZ304402B6 (cs) 2014-04-16
NZ516517A (en) 2003-10-31
IL147563A0 (en) 2002-08-14
AR022646A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
BR9811248B1 (pt) variante de enzima subtilase derivada de uma subtilase originária selecionada a partir do sub-grupo i-s1 ou do sub-grupo i-s2, dita variante tendo melhorado desempenho de lavagem em detergentes em comparação com a subtilase originária, sequência de dna isolada, vetor de expressão, célula hospedeira microbiana, processo para produzir uma variante, composição, uso de uma variante de subtilase.
UA87462C2 (ru) Применение соединений, которые принимают участие в биосинтезе нуклеиновых кислот как криопротекторные агенты
UY26287A1 (es) Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1
CO5070698A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1
UY26286A1 (es) Gen de streptomyces avermitilis que dirige la relación de avermectinas b2:b1
CY1112491T1 (el) Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1
EP2484759A3 (en) Methods of refolding mammalian glycosyltransferases
CA2167520A1 (en) Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
BR0110128A (pt) Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase
ATE309368T1 (de) Verfahren zur produktion von koenzym q10
CO4340655A1 (es) Genes que codifican el complejo alfa-cetoacido deshidrogena- sa de cadena ramificada de streptomyces avermitilis
CA2450691A1 (en) Genes and proteins involved in the biosynthesis of lipopeptides

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20110721